We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
-1.25%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$16.9B
AUM Growth
-$410M
Cap. Flow
-$25.6M
Cap. Flow %
-0.15%
Top 10 Hldgs %
24.81%
Holding
859
New
90
Increased
491
Reduced
223
Closed
46

Sector Composition

Rank Sector Weight
1 Materials 41.11%
2 Energy 24.53%
3 Healthcare 8.07%
4 Technology 3.76%
5 Industrials 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFCFA
101
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$42.9M 0.25%
+1,318,100
New +$44.3M
VAR
102
DELISTED
Varian Medical Systems, Inc.
VAR
$42.3M 0.25%
572,678
+572,296
+149,816% +$44.8M
BEN icon
103
Franklin Resources
BEN
$17.6B
$42.3M 0.25%
862,524
+861,289
+69,740% +$44.2M
HSY icon
104
Hershey
HSY
$35.2B
$42.3M 0.25%
475,725
+475,141
+81,360% +$44.8M
SE
105
DELISTED
Spectra Energy Corp Wi
SE
$42.2M 0.25%
1,294,672
-31,661
-2% -$1.13M
TSCO icon
106
Tractor Supply
TSCO
$16.1B
$42.1M 0.25%
2,343,005
+177,435
+8% +$3.15M
ITC
107
DELISTED
ITC HOLDINGS CORP
ITC
$42.1M 0.25%
+1,307,283
New +$45.6M
AXP icon
108
American Express
AXP
$227B
$42M 0.25%
+539,769
New +$42.8M
USB icon
109
US Bancorp
USB
$98.2B
$41.9M 0.25%
+965,950
New +$42.2M
BRK.B icon
110
Berkshire Hathaway Class B
BRK.B
$1.1T
$41.8M 0.25%
+307,285
New +$43.8M
BMRN icon
111
BioMarin Pharmaceuticals
BMRN
$11.6B
$39.6M 0.23%
289,507
-12,097
-4% -$1.5M
ESV
112
DELISTED
Ensco Rowan plc
ESV
$39.4M 0.23%
442,011
-45,095
-9% -$4.39M
WMS icon
113
Advanced Drainage Systems
WMS
$10.6B
$39.2M 0.23%
1,335,900
-39,900
-3% -$1.18M
REGN icon
114
Regeneron Pharmaceuticals
REGN
$78.5B
$39.2M 0.23%
76,770
-13,570
-15% -$6.62M
RIG icon
115
Transocean
RIG
$5.89B
$38.7M 0.23%
2,399,564
-32,478
-1% -$585K
ILMN icon
116
Illumina
ILMN
$31B
$35.9M 0.21%
168,898
-17,635
-9% -$3.44M
SSRI
117
DELISTED
Silver Standard Resources
SSRI
$35.2M 0.21%
5,602,018
-1,273,159
-19% -$7.52M
INCY icon
118
Incyte
INCY
$24.2B
$35M 0.21%
335,432
+23,970
+8% +$2.48M
VRTX icon
119
Vertex Pharmaceuticals
VRTX
$121B
$34.9M 0.21%
282,777
+1,315
+0.5% +$166K
GAU
120
Galiano Gold
GAU
$455M
$32.2M 0.19%
18,354,118
-1,675,268
-8% -$2.7M
LSG
121
DELISTED
LAKE SHORE GOLD CORP
LSG
$31.1M 0.18%
30,217,558
-6,858,714
-18% -$6.72M
FSM icon
122
Fortuna Silver Mines
FSM
$2.55B
$30.9M 0.18%
8,441,138
-1,040,893
-11% -$3.91M
CLB icon
123
Core Laboratories
CLB
$488M
$29.9M 0.18%
262,600
-411,500
-61% -$49.9M
OII icon
124
Oceaneering
OII
$4.86B
$29.1M 0.17%
624,676
-12,352
-2% -$649K
NVS icon
125
Novartis
NVS
$297B
$29M 0.17%
329,255
-28,040
-8% -$2.57M

Similar funds

VanEck Associates's Q2 2015 Portfolio in Review

As of Q2 2015, VanEck Associates held 859 positions worth $16.9B, down 2.4% from $17.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

VanEck Associates's Q2 2015 filing shows 90 new, 491 increased, 223 reduced and 46 closed positions. Its largest new stake was ITC HOLDINGS CORP: 1,307,283 shares worth $42.1M. The largest sale was Marathon Oil Corporation, an estimated $108M.

By sector, the portfolio is most concentrated in Materials at 41% of assets, down from 42% a quarter earlier, followed by Energy and Healthcare.

  • VanEck Associates's largest Q2 2015 buy was ITC HOLDINGS CORP: 1,307,283 shares worth $42.1M.
  • VanEck Associates added most to Tahoe Resources Inc in Q2 2015, an estimated $203M increase.
  • VanEck Associates's biggest Q2 2015 reduction was Marathon Oil Corporation, cutting an estimated $108M.
  • VanEck Associates fully exited Express Scripts Holding Company in Q2 2015, selling an estimated $47.8M.
  • VanEck Associates's ten largest holdings make up 25% of its $16.9B portfolio in Q2 2015.
  • VanEck Associates opened 90 new positions and closed 46 in Q2 2015.
  • VanEck Associates's portfolio value fell 2.4% quarter-over-quarter to $16.9B.

Based on VanEck Associates's 13F filing for Q2 2015, filed 12 Aug 2015.